Products for Research Use Only
RegisterLogin

KRN2

CAT: 0804-HY-112125-02Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-112125-02Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KRN2 is a selective inhibitor of nuclear factor of activated T cells (NFAT5), with an IC50 of 100 nM. KRN2 has potential to treat NFAT5-mediated Chronic Arthritis[1].
CAS Number
248260-75-5
UNSPSC
12352005
Target
Nuclear Factor of activated T Cells (NFAT)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/KRN2.html
Purity
98.04
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
COC1=C(OC)C2=C[N+]3=C(C(C(CC3)=C4)=CC5=C4OCO5)C(CC6=CC=CC=C6F)=C2C=C1.[Cl-]
Molecular Formula
C27H23ClFNO4
Molecular Weight
479.93
References & Citations
[1]Han EJ, et al. Suppression of NFAT5-mediated Inflammation and Chronic Arthritis by Novel κB-binding Inhibitors. EBioMedicine. 2017 Apr;18:261-273.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Citation 01
J Immunol. 2021 Jun 1;206 (11) :2652-2667.|Johns Hopkins University. 2025.|Biomolecules. 2024 Nov 13;14 (11) :1444.|J Immunol. 2021 Jun 1;206 (11) :2652-2667.

Chemical Information

13-[(2-Fluorophenyl)methyl]-5,6-dihydro-9,10-dimethoxy-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium chloride

KRN2 is a selective inhibitor of nuclear factor of activated T cells (NFAT5), with an IC50 of 100 nM. KRN2 has potential to treat NFAT5-mediated Chronic Arthritis.

CAS Number248260-75-5
PubChem CID134814485
IUPAC Name21-[(2-fluorophenyl)methyl]-16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene chloride
Molecular FormulaC27H23ClFNO4
Molecular Weight479.9
Topological Polar Surface Area40.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Heavy Atom Count34
Formal Charge0
Complexity681
SMILES
COC1=C(C2=C[N+]3=C(C4=CC5=C(C=C4CC3)OCO5)C(=C2C=C1)CC6=CC=CC=C6F)OC.[Cl-]
InChI
InChI=1S/C27H23FNO4.ClH/c1-30-23-8-7-18-20(11-17-5-3-4-6-22(17)28)26-19-13-25-24(32-15-33-25)12-16(19)9-10-29(26)14-21(18)27(23)31-2;/h3-8,12-14H,9-11,15H2,1-2H3;1H/q+1;/p-1
InChIKey
RPHFGOXVJGNJJH-UHFFFAOYSA-M
Chemical Structure
2D Structure
2D structure of 13-[(2-Fluorophenyl)methyl]-5,6-dihydro-9,10-dimethoxy-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium chloride
CAS: 248260-75-5
CID: 134814485
Formula: C27H23ClFNO4
MW: 479.9
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight479.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass479.1299641
Monoisotopic Mass479.1299641
Topological Polar Surface Area40.8 Ų
Heavy Atom Count34
Formal Charge0
Complexity681
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-112126-01KRN5
HY-12060-01KRN-633
HY-P990611KRN-330
HY-19116KRN-2391
HY-12060R-01KRN-633 (Standard)

Alternative Products

CatalogName
T11781-01KRN2
MBS3614913-01KRN2 bromide
A20282-25KRN2 25mg
A20282-10KRN2 10mg
A20282-100KRN2 100mg
A20282-50KRN2 50mg
A20282-5KRN2 5mg
A21549-50KRN2 bromide 50mg
A21549-100KRN2 bromide 100mg
A21549-10KRN2 bromide 10mg

Popular Products